Lilly’s Kisunla shines in first DTC ad for Alzheimer’s med
A year after earning FDA approval for Kisunla, Eli Lilly is shining a light on the anti-amyloid Alzheimer’s disease therapy in its first branded campaign. The...
A year after earning FDA approval for Kisunla, Eli Lilly is shining a light on the anti-amyloid Alzheimer’s disease therapy in its first branded campaign. The...
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.